Abstract

Dry extracts from the Eurasian plants, Ajuga turkestanica, Eurycoma longifolia, and Urtica dioica have been used as anabolic supplements, despite the limited scientific data on these effects. To assess their actions on early sarcopenia signs, male and female castrated mice were supplemented with lyophilized extracts of the three plants, isolated or in association (named TLU), and submitted to resistance exercise. Ovariectomy (OVX) led to body weight increase and non-high-density cholesterol (HDL) cholesterol elevation, which had been restored by exercise plus U. dioica extract, or by exercise and TLU, respectively. Orchiectomy (ORX) caused skeletal muscle weight loss, accompanied by increased adiposity, being the latter parameter reduced by exercise plus E. longifolia or U. dioica extracts. General physical activity was improved by exercise plus herbal extracts in either OVX or ORX animals. Exercise combined with TLU improved resistance to fatigue in OVX animals, though A. turkestanica enhanced the grip strength in ORX mice. E. longifolia or TLU also reduced the ladder climbing time in ORX mice. Resistance exercise plus herbal extracts partly altered gastrocnemius fiber size frequencies in OVX or ORX mice. We provide novel data that tested ergogenic extracts, when combined with resistance exercise, improved early sarcopenia alterations in castrated male and female mice.

Highlights

  • IntroductionDeclining of hormonal levels in aging is a predictor factor for the onset of skeletal muscle loss and related diseases, such as sarcopenia [1,2,3,4]

  • Considering the abovementioned evidence, the present study aimed to evaluate the anti-sarcopenic properties of A. turkestanica, E. longifolia, and U. dioica extracts, supplemented alone or in an association scheme, comparing the possible beneficial actions in castrated males and females submitted to resistance exercise

  • In this study, using castrated mice, we showed that phytoanabolic extracts of the Eurasian plants A. turkestanica, E. longifolia, and U. dioica, or TLU, differently modulated several parameters related to hormone reduction, such as muscle mass, adiposity, muscle strength, fatigue, general locomotor activity, and lipid profile

Read more

Summary

Introduction

Declining of hormonal levels in aging is a predictor factor for the onset of skeletal muscle loss and related diseases, such as sarcopenia [1,2,3,4]. Sarcopenia is characterized by a progressive reduction in muscle quantity and quality, leading to impaired movement, lessened strength, with an increased risk of injuries secondary to falls, being often associated with frailty [5,6]. Current treatments are focused on hormone replacement therapy, which might display adverse effects including exacerbation of sleep apnea, delayed wound healing, gynecomastia, increased volume of red blood cells, higher risk of cardiovascular diseases and cancer, besides virilization in women [15,16]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call